50
Participants
Start Date
August 31, 2011
Primary Completion Date
June 30, 2018
Study Completion Date
July 1, 2019
Anti-TNF
All participants in this arm receive an anti-TNF for the treatment of luminal CD. They are required to undergo study visits at baseline, 2 months, and 6 months in addition to any other routine visits. Sexual function, body image, disease activity, quality of life, and depression scores will be measured at baseline and at each study visit during the 6-month study.
Anti-TNF
All participants in this arm receive an anti-TNF for the treatment of perianal CD. They are required to undergo study visits at baseline, 2 months, and 6 months in addition to any other routine visits. Sexual function, body image, disease activity, quality of life, and depression scores will be measured at baseline and at each study visit during the 6-month study.
Steroids
All participants in this arm receive steroids for the treatment of luminal CD. They are required to undergo study visits at baseline, 2 months, and 6 months in addition to any other routine visits. Sexual function, body image, disease activity, quality of life, and depression scores will be measured at baseline and at each study visit during the 6-month study.
Mercy Medical Center, Baltimore
University of Maryland School of Medicine, Baltimore
Penn State Hershey Medical Center, Hershey
Vanderbilt University, Nashville
Collaborators (1)
Vanderbilt University
OTHER
Milton S. Hershey Medical Center
OTHER
Mercy Medical Center
OTHER
University of Maryland, Baltimore
OTHER